Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-916-0 | CAS number: 111-86-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Octylamine is harmful if swallowed (oral , rat : LD50 < 200 mg/kg bw ) or inhaled (LC50(rat, 4 hr) :1.6 mg/L ). The LD50 (dermal, rabbit) was between 200 mg/kg bw and 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- The test substance was administered orally at a dose level of 200 mg/kg bw to 5 male and 5 female rats. The animals were then observed for 21 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. K. Thomae GmbH
- Age at study initiation: young adults
- Weight at study initiation: mean males: 191 g; mean females: 179 g
- Fasting period before study: the animals were given no feed about 16 hours before administration
- Housing: 5 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 0.26 ml/kg
- Doses:
- 200 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 21 days
- Frequency of observations and weighing: recording of signs and symptoms several times on the day of administration and at least once each workday; Check for moribund and dead animals twice each workday and once on holidays. Weighing was performed on day 0, day 6, day 13, day 20.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- < 200 mg/kg bw
- Mortality:
- 2/5 male animals and 5/5 female animals died
- Clinical signs:
- other: male animals: poor general state, dyspnoea, apathy, staggering, piloerection, exsiccosis, salivation, weight reduction, discoloured urine (red) female animals: poor general state, dyspnoea, apathy, staggering, piloerection, smeared fur, exsiccosis, weight
- Gross pathology:
- animals that died: general congestion
lungs: intensified emphysema in one animal, emaciation in two animals; these two animals died after 10 and 20 days.
sacrificed animals:
no pathologic findings noted - Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 of n-octylamine was determined to be below 200 mg/kg.
- Executive summary:
In a non-GLP study that was conducted similar to OECD TG 401, n-octylamine was administered at 200 mg/kg bw by oral gavage to male and female rats (5 animals per sex and dose) that were fasted 16 h before administration. Signs of toxicity included poor general state, dyspnoea, apathy, staggering, piloerection, exsiccosis, salivation, weight reduction, discoloured urine (red), smeared fur, and snout red crusted. At 200 mg/kg bw, 2/5 male animals and 5/5 female animals died. Gross lesions of the animals that died included general congestion, intensified emphysema (one animal), and emaciation (two animals) of the lungs. The acute oral LD50 in rats was below 200 mg/kg bw (BASF, 1990).
Reference
Mortality
Dose (mg/kg) | No. of animals | Died within1h | 1 day | 2 days | 7 days | 14 days | 21 days |
200 | 5 male | 0 | 1 | 1 | 1 | 1 | 2 |
200 | 5 female | 2 | 4 | 4 | 4 | 4 | 5 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 200 mg/kg bw
- Quality of whole database:
- good quality, guideline studies available, result supported by several studies
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Rats (10/sex/dose) were exposed to an aerosol (seven different doses) of the test substance (head/nose exposure) for 4 hours. The rats were then observed for 14 days and the LC50 was calculated.
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: WIGA, Sulzfeld and MUS RATTUS, Brunnthal
- Weight at study initiation: 185 +- 15 g
- Diet: ad libitum
- Water: ad libitum
no further data
ENVIRONMENTAL CONDITIONS
no data - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
continuous infusion pump UNITA (B. Braun), two substance injector (Rhema Jato)
The test substance was fed in a constant amount using a continuous infusion pump into a two substance injector. Compressed air (up to 3 bar) was
used to generate ab aerosol which was then fed into the exposure chamber. The pressure in the inhalation system was adjusted to 3 Pa to generate
over pressure.
TEST ATMOSPHERE
- Brief description of analytical method used: the atmosphere in the exposure chamber was analyzed using gas chromatography
- Samples taken from breathing zone: yes
no further data - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- using gas chromatography
- Duration of exposure:
- 4 h
- Concentrations:
- 0.13, 0.76, 1.44, 1.57, 1.64, 2.58, 9.85 mg/l (analytical concentration)
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were performed daily, weighing on day 0, day 7 and day 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross patholody - Statistics:
- Probitanalysis according to D.J. Finney in the BASF computing center
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 1.6 mg/L air
- Exp. duration:
- 4 h
- Mortality:
- 4 hour exposure:
at 0.13 mg/l 0/10 male and 0/10 female rats died; at 0.76 mg/l 1/10 male and 0/10 female rats died; at 1.44 mg/l 4/10 male and 1/10 female animals died; at 1.57 mg/l 3/10 male and 1/10 female animals died; at 1.64 mg/l 5/10 male and 7/10 female animals died; at 2.58 mg/l 9/10 male and 10/10 female animals died; at 9.85 mg/l 10/10 male and 10/10 female animals died - Clinical signs:
- other: 0.13 mg/l dose group: aqueous to reddish secretion from the eyes and nose, animals were free of signs of toxicity after 2 days 0.76-2.58 mg/l dose group: attempts to escape, aqueous to reddish secretion from the eyes and nose, eye lid closure, intermitten
- Body weight:
- There were no significant changes in weight gain in most dose groups, most animals gained weight normally.
Male rats of the 1.44 mg/l dose group showed a reduced weight gains compared to controls and the surviving male animal of the 2.58 mg/l dose group also showed a reduced weight gain. - Gross pathology:
- animals that died:
heart: acute dilation of the antechambers, acute congestive hyperemia
lung: striking hyperemia, oedematous
sacrificed animals: organs without findings - Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test the LC50 in rats was 1.6 mg/L.
- Executive summary:
Sprague-Dawley rats (10 animals per sex and dose) were exposed against 0, 0.13, 0.76, 1.44, 1.57, 1.64, 2.58, 9.85 mg substance/l (analytical concentration) for 4 h (nose only exposure). The animals were observed for 14 days.
at 0.13 mg/l 0/10 male and 0/10 female rats died; at 0.76 mg/l 1/10 male and 0/10 female rats died; at 1.44 mg/l 4/10 male and 1/10 female animals died; at 1.57 mg/l 3/10 male and 1/10 female animals died; at 1.64 mg/l 5/10 male and 7/10 female animals died; at 2.58 mg/l 9/10 male and 10/10 female animals died; at 9.85 mg/l 10/10 male and 10/10 female animals died. The LC50 in rats was dertermined with 1.6 mg/L.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 600 mg/m³ air
- Quality of whole database:
- sufficient quality, key study similar to guideline
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions ( observation period 7 days; limited documentation, i.e. no details reported (location; size of treated area; exposure duration; washing etc.)
- Principles of method if other than guideline:
- Method: three dose levels tested, observation period 7 days; however, no details reported (location; size of treated area; exposure duration; washing)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 60-85°F - Type of coverage:
- not specified
- Vehicle:
- other: none
- Details on dermal exposure:
- Project No. 6006-85
Protocal No. C22/AO-MSDS - Duration of exposure:
- no data
- Doses:
- 200, 2000, and 3000 mg/kg bw
- No. of animals per sex per dose:
- 4
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 17 days
- Statistics:
- none
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- 200 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- LD100
- Effect level:
- 2 000 mg/kg bw
- Mortality:
- Within 7 days no deaths (0/4) at 200 mg/kg bw; all animals dead at 2000 mg/kg bw (4/4, within 2 days) and at 3000 mg/kg bw (4/4, within 1 day)
- Clinical signs:
- other: At 200 mg/kg, dermal necrosis At the high doses, hypoactivity and prostration prior to death
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Dermal LD50 (rabbit): 200 mg/kg bw
- Executive summary:
The dermal toxicity of n-octylamine was tested in rabbits (4 animals per dose) at 200, 2000, and 3000 mg/kg bw. The observation period was 7 days, other methodological details were not reported. However, the study is regarded to be reliable with restrictions.
All animals at 3000 and 2000 mg/kg bw died within one or two days, respectively. There were no deaths within 7 days after treatment in rabbits receiving 200 mg/kg bw but dermal necrosis at the test sites. The LD50 (dermal, rabbit) was therefore higher than 200 mg/kg bw and less than 2000 mg/kg bw (Biodynamics, 1985).
Reference
MORTALITY:
200 mg/kg bw: 0/4 animals
2000 mg/kg bw: 4/4 animals
3000 mg/kg bw: 4/4 animals
CLINICAL SIGNS:
At 200 mg/kg, dermal necrosis
At the high doses, hypoactivity and prostration
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 201 mg/kg bw
- Quality of whole database:
- sufficient quality, key study similar to guideline
Additional information
Oral toxicity:
The estimated oral LD 50 in rat was below 200 mg/kg bw in Key study (BASF, 1990)
In a non-GLP study that was conducted similar to OECD TG 401, n-octylamine was administered at 200 mg/kg bw by oral gavage to male and female rats (5 animals per sex and dose) that were fasted 16 h before administration. Signs of toxicity included poor general state, dyspnoea, apathy, staggering, piloerection, exsiccosis, salivation, weight reduction, discoloured urine (red), smeared fur, and snout red crusted. At 200 mg/kg bw, 2/5 male animals and 5/5 female animals died. Gross lesions of the animals that died included general congestion, intensified emphysema (one animal), and emaciation (two animals) of the lungs. The acute oral LD50 in rats was below 200 mg/kg bw (BASF, 1990).
Following a pretests using 2 animals of either sex, octylamine was administered at 250 mg/kg bw by oral gavage to male and female rats that were fasted overnight in a limit test (GLP, similar to OECD TG 401). Clinical signs observed during the first 8 days postdose included salivation, breathing abnormalities, decreased activity, dark material around the facial area, decreased defecation, rough hair, urine stains, and dehydration. Males gained body weight during the study, whereas females lost weight. There were 2 mortalities in the female group during the 14-day observation period. Necropsy revealed signs of local irritation in survivors (thickened mucosa of the nonglandular stomach and reduced body fat) and in animals that died (colored mucoid contents in the digestive tract, and black foci on the stomach). As mortality was low (2/10 animals died), it was concluded that the LD50-value is >250 mg/kg bw (Springborn, 1990).
In a non-GLP study that was conducted similar to OECD TG 401, octylamine was administered at 50, 108, 232, 500, and 1076 mg/kg bw by oral gavage to male and female rats (5 animals per sex and dose) that were fasted overnight. The doses were selected based on the results of a preliminary study using 1 rat per sex and dose, at dose levels from 25 to 500 mg/kg bw. In the main study, all animals at 50 and 108 mg/kg bw survived. Signs of toxicity included piloerection and reduced activity which subdued within 24 hours. At 232 mg/kg bw, one female died. Clinical signs at this dose level (piloerection and slight tremors) subsided within 48 hours after treatment. All animals at 500 and 1076 mg/kg bw died. All deaths occurred within 30 to 60 minutes after dosing. The acute oral LD50 in rats was 315 mg/kg bw (Safepharm, 1980).
Two non-reliable studies (BASF, 1976 and Hoechst 1986) determined LD50 values of 783 mg/kg bw or 200 - 500 mg/kg bw respectively.
Overall, the analysis shows, that apart from the key study all studies showed LD50 values above 200 mg/kg bw.In the key study an LD50 value of < 200 mg/kg bw was determined. It can be concluded that an oral LD50 value below 50 mg/kg bw is highly unlikely.
Inhalation:
Sprague-Dawley rats (10 rats per sex and dose) were exposed to n-octylamine at 0.13, 0.76, 1.44, 1.57, 1.64, 2.58, and 9.85 mg/L (analytical concentrations; aerosol/vapor; head-only exposure, duration 4 hours) in a valid non-GLP pre-guideline study that was basically similar to OECD TG 403. Lacrimation and nasal discharge but no mortality was seen at 0.13 mg/L until 1 day after treatment. Dyspnea, trembling, unsteady gait, rough fur, hunched posture and corneal opacity were seen in a dose-dependent manner in groups at 0.76 – 9.85 mg/L. Deaths occurred during exposure in the highest dose group, and on the day of treatment in all other groups. Necropsy revealed acute atria dilatation and hyperemic, edematous lungs in animals that died, but no particular findings in animals that survived. The combined male and female LC50(rat, 4 hr) was 1.6 mg/L (BASF, 1979).
Dermal toxicity:
The dermal toxicity of n-octylamine was tested in rabbits (4 animals per dose) at 200, 2000, and 3000 mg/kg bw. The observation period was 7 days, other methodological details were not reported. However, the study is regarded to be reliable with restrictions.
All animals at 3000 and 2000 mg/kg bw died within one or two days, respectively. There were no deaths within 7 days after treatment in rabbits receiving 200 mg/kg bw but dermal necrosis at the test sites. The LD50 (dermal, rabbit) was therefore higher than 200 mg/kg bw and less than 2000 mg/kg bw (Biodynamics, 1985).
In a non-GLP study with 10 rabbits (5 males and 5 females) no animal died after dermal application of 200 mg/kg bw (24 h occlusive) during the 8 days observation period. The animals showed necrosis at the application site. This study supports the finding that the dermal LD50 is > 200 mg/kg bw (BASF AG, 1979).
Justification for selection of acute toxicity – oral endpoint
reliable guideline study, lowest LD50 observed in different studies
Justification for selection of acute toxicity – inhalation endpoint
reliable study, similar to guideline
Justification for selection of acute toxicity – dermal endpoint
reliable study, similar to guideline
Justification for classification or non-classification
According to the criteria set in Regulation (EC) No 1272/2008 a classification for acute oral and dermal toxicity Category 3 and acute inhalation toxicity Category 4 is required as available data indicate that oral LD50 is below 200 mg/kg bw, dermal LD50 is between 200 and 2000 mg/kg bw and the inhalation LC50 is 1.6 mL/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.